Andrew Bodnar, a former top executive at Bristol-Myers Squibb…faces up to a year in jail after pleading guilty to lying to federal officials about a deal to block a generic version of the company's top-selling medicine…Bristol-Myers in 2007 agreed to plead guilty and pay a $1 million fine for misleading the government about its efforts to stop Apotex from selling a cheap form of…Plavix in the United States…"The prosecutions…should send a strong message to the pharmaceutical community that attempts to undermine the federal government's critical role of ensuring Americans have access to life-saving drugs…at the most competitive prices will not be tolerated," Acting Assistant Attorney General Scott Hammond said.